Synthesis and structure-activity relationships of USP48 deubiquitinylase inhibitors

被引:1
作者
Boehm, Kevin [1 ,2 ]
Schulze-Niemand, Eric [1 ]
Kaehne, Thilo [1 ]
Siddiqui, Elisa [1 ]
Taeger, Christian [1 ]
Ramsbeck, Daniel [2 ]
Buchholz, Mirko [2 ]
Naumann, Michael [1 ,3 ,4 ]
机构
[1] Otto Guericke Univ, Inst Expt Internal Med, Magdeburg, Germany
[2] Fraunhofer Inst Cell Therapy & Immunol IZI, Dept Drug Design & Target Validat MWT, Bioctr, Halle, Germany
[3] Otto Guericke Univ, Inst Expt Internal Med, Med Fac, Leipziger Str 44, D-39120 Magdeburg, Germany
[4] PerioTrap Pharmaceut GmbH, Bioctr, Halle, Germany
关键词
chemical synthesis; drug design; papain-like protease; ubiquitin-specific proteases; USP2; SMALL-MOLECULE INHIBITOR; UBIQUITIN; SPECIFICITY; DISCOVERY; CELLS;
D O I
10.1002/ardp.202200661
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Ubiquitin-specific proteases represent a family of enzymes that catalyze the cleavage of ubiquitin from specific substrate proteins to regulate their activity. USP48 is a rarely studied USP, which has recently been linked to inflammatory signaling via regulation of the transcription factor nuclear factor kappa B. Nonetheless, a crystal structure of USP48 has not yet been resolved and potent inhibitors are not known. We screened a set of 14 commercially available USP inhibitors for their activity against USP48 and identified the USP2 inhibitor "ML364" as a candidate for further optimization. Using a ligand-based approach, we derived and synthesized a series of ML364 analogs. The IC50 concentrations of the new compounds to inhibit USP48 were determined in a deubiquitinylase activity assay by measuring the fluorescence intensity using tetra-ubiquitin rhodamine110 as substrate. A compound containing a carboxylic acid functionalization (17e) inhibited USP48 activity toward tetra-ubiquitin rhodamine110 with an IC50 of 12.6 mu M. Further structure-based refinements are required to improve the inhibition activity and specificity.
引用
收藏
页数:17
相关论文
共 37 条
  • [1] Ausländer D, 2018, NAT METHODS, V15, P57, DOI [10.1038/NMETH.4505, 10.1038/nmeth.4505]
  • [2] NEDD8 and ubiquitin ligation by cullin-RING E3 ligases
    Baek, Kheewoong
    Scott, Daniel C.
    Schulman, Brenda A.
    [J]. CURRENT OPINION IN STRUCTURAL BIOLOGY, 2021, 67 : 101 - 109
  • [3] A Small Molecule Inhibitor of Ubiquitin-Specific Protease-7 Induces Apoptosis in Multiple Myeloma Cells and Overcomes Bortezomib Resistance
    Chauhan, Dharminder
    Tian, Ze
    Nicholson, Benjamin
    Kumar, K. G. Suresh
    Zhou, Bin
    Carrasco, Ruben
    McDermott, Jeffrey L.
    Leach, Craig A.
    Fulcinniti, Mariaterresa
    Kodrasov, Matthew P.
    Weinstock, Joseph
    Kingsbury, William D.
    Hideshima, Teru
    Shah, Parantu K.
    Minvielle, Stephane
    Altun, Mikael
    Kessler, Benedikt M.
    Orlowski, Robert
    Richardson, Paul
    Munshi, Nikhil
    Anderson, Kenneth C.
    [J]. CANCER CELL, 2012, 22 (03) : 345 - 358
  • [4] 6-Thioguanine is a noncompetitive and slow binding inhibitor of human deubiquitinating protease USP2
    Chuang, Shang-Ju
    Cheng, Shu-Chun
    Tang, Hui-Chi
    Sun, Chiao-Yin
    Chou, Chi-Yuan
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [5] Breaking the chains: deubiquitylating enzyme specificity begets function
    Clague, Michael J.
    Urbe, Sylvie
    Komander, David
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2019, 20 (06) : 338 - 352
  • [6] Colland, 2012, [No title captured], Patent No. [WO2013030218(A1), 20130302181]
  • [7] The therapeutic potential of deubiquitinating enzyme inhibitors
    Colland, Frederic
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2010, 38 : 137 - 143
  • [8] Synthesis and Biological Evaluation of 9-Oxo-9H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile Analogues as Potential Inhibitors of Deubiquitinating Enzymes
    Colombo, Matteo
    Vallese, Stefania
    Peretto, Ilaria
    Jacq, Xavier
    Rain, Jean-Christophe
    Colland, Frederic
    Guedat, Philippe
    [J]. CHEMMEDCHEM, 2010, 5 (04) : 552 - 558
  • [9] Deubiquitinase inhibition as a cancer therapeutic strategy
    D'Arcy, Padraig
    Wang, Xin
    Linder, Stig
    [J]. PHARMACOLOGY & THERAPEUTICS, 2015, 147 : 32 - 54
  • [10] Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma Models
    Davis, Mindy I.
    Pragani, Rajan
    Fox, Jennifer T.
    Shen, Min
    Parmar, Kalindi
    Gaudiano, Emily F.
    Liu, Li
    Tanega, Cordelle
    McGee, Lauren
    Hall, Matthew D.
    McKnight, Crystal
    Shinn, Paul
    Nelson, Henrike
    Chattopadhyay, Debasish
    D'Andrea, Alan D.
    Auld, Douglas S.
    DeLucas, Larry J.
    Li, Zhuyin
    Boxer, Matthew B.
    Sinneonov, Anton
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (47) : 24628 - 24640